A
Anteris Technologies Global Corp
NASDAQ:AVR
Anteris Technologies Global Corp
NASDAQ:AVR
Price:
6.29
USD
Market Cap:
$611.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Anteris Technologies Global Corp
NASDAQ:AVR
|
US |
|
Jatcorp Ltd
ASX:JAT
|
AU |
|
Orient Green Power Company Ltd
NSE:GREENPOWER
|
IN |
|
Quickstep Holdings Ltd
OTC:QCKSF
|
AU |
|
One Group Hospitality Inc
NASDAQ:STKS
|
US |
|
InfoNet Inc
TSE:4444
|
JP |
|
A
|
Avrupa Yatirim Holding AS
IST:AVHOL.E
|
TR |
|
WT Microelectronics Co Ltd
TWSE:3036
|
TW |
|
P
|
Pezm Gold Inc
XTSX:PEZM.H
|
CA |
|
Compagnie des Alpes SA
PAR:CDA
|
FR |
|
Guosheng Financial Holding Inc
SZSE:002670
|
CN |
|
Defence Tech Holding SpA
MIL:DTH
|
IT |
|
A
|
Activation Group Holdings Ltd
HKEX:9919
|
CN |
|
J
|
Jiangsu Tongli Risheng Machinery Co Ltd
SSE:605286
|
CN |
|
Karat Packaging Inc
NASDAQ:KRT
|
US |
|
Promisia Healthcare Ltd
NZX:PHL
|
NZ |
|
H
|
Hipromine SA
WSE:HPM
|
PL |
|
D
|
Digital Chosun
KOSDAQ:033130
|
KR |
Multiples-Based Value
The Multiples-Based Value of one AVR stock under the Base Case scenario is hidden USD. Compared to the current market price of 6.29 USD, Anteris Technologies Global Corp is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
AVR Multiples-Based Value
LOCKED
Multiples Across Competitors
AVR Competitors Multiples
Anteris Technologies Global Corp Competitors
Anteris Technologies Global Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
A
|
Anteris Technologies Global Corp
NASDAQ:AVR
|
611.6m USD | 319.7 | -6.5 | -6.5 | -6.4 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
176.4B USD | 3.8 | 25.7 | 14.7 | 20.2 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
166.3B USD | 16.1 | 56.6 | 42.9 | 52.7 | |
| US |
|
Stryker Corp
NYSE:SYK
|
130.5B USD | 5.1 | 39.7 | 20.3 | 24.6 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
111.8B USD | 3.1 | 23.9 | 13.2 | 19.2 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
95.8B USD | 4.7 | 32.6 | 19.3 | 26 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
43.3B EUR | 1.9 | 20.5 | 11.4 | 16.1 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
46.3B USD | 10.6 | 43.1 | 30.5 | 33.7 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
45.4B USD | 7.5 | 42.4 | 23 | 25.2 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.3B USD | 2 | 25.1 | 10 | 16.8 | |
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
33.5B USD | 1.6 | 16 | 11.5 | 13.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
